View Item 

Show simple item record

Current epidemiology of hepatitis E virus infection in the United States: Low seroprevalence in the National Health and Nutrition Evaluation Survey

dc.contributor.authorDitah, Ivoen_US
dc.contributor.authorDitah, Faustaen_US
dc.contributor.authorDevaki, Pardhaen_US
dc.contributor.authorDitah, Calistusen_US
dc.contributor.authorKamath, Patrick S.en_US
dc.contributor.authorCharlton, Michaelen_US
dc.date.accessioned2014-09-03T16:52:20Z
dc.date.availableWITHHELD_13_MONTHSen_US
dc.date.available2014-09-03T16:52:20Z
dc.date.issued2014-09en_US
dc.identifier.citationDitah, Ivo; Ditah, Fausta; Devaki, Pardha; Ditah, Calistus; Kamath, Patrick S.; Charlton, Michael (2014). "Current epidemiology of hepatitis E virus infection in the United States: Low seroprevalence in the National Health and Nutrition Evaluation Survey." Hepatology 60(3): 815-822.en_US
dc.identifier.issn0270-9139en_US
dc.identifier.issn1527-3350en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/108373
dc.publisherWiley Periodicals, Inc.en_US
dc.titleCurrent epidemiology of hepatitis E virus infection in the United States: Low seroprevalence in the National Health and Nutrition Evaluation Surveyen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelInternal Medicine and Specialtiesen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/108373/1/hep27219.pdf
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/108373/2/hep27219-sup-0001-suppinfo.pdf
dc.identifier.doi10.1002/hep.27219en_US
dc.identifier.sourceHepatologyen_US
dc.identifier.citedreferenceCenters for Disease Control. Available at: http://www.cdc.gov/nchs/data/nhanes/nhanes_09_10/HEPE_F_met_IgG_antibody.pdf. Division of Viral Hepatitis, National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention, 2012.en_US
dc.identifier.citedreferenceMast EE, Alter MJ, Holland PV, Purcell RH. Evaluation of assays for antibody to hepatitis E virus by a serum panel. Hepatitis E Virus Antibody Serum Panel Evaluation Group. Hepatology 1998; 27: 857 – 861.en_US
dc.identifier.citedreferenceHerremans M, Bakker J, Duizer E, Vennema H, Koopmans MP. Use of serological assays for diagnosis of hepatitis E virus genotype 1 and 3 infections in a setting of low endemicity. Clin Vaccine Immunol 2007; 14: 562 – 568.en_US
dc.identifier.citedreferenceCenters for Disease Control and Prevention. About the National Health and Nutrition Examination Survey (NHANES) Available at: www.cdc.gov/nchs/about/major/nhanes/intro_mec.htm. Accessed May 13, 2013. N/A 2009.en_US
dc.identifier.citedreferenceDrobeniuc J, Greene‐Montfort T, Le NT, Mixson‐Hayden TR, Ganova‐Raeva L, Dong C, et al. Laboratory‐based surveillance for hepatitis E virus infection, United States, 2005‐2012. Emerg Infect Dis 2013; 19: 218 – 222.en_US
dc.identifier.citedreferenceCenters for Disease Control and Prevention. About the National Health and Nutrition Examination Survey (NHANES). 2009.en_US
dc.identifier.citedreferenceHoofnagle JH, Nelson KE, Purcell RH. Hepatitis E. N Engl J Med 2012; 367: 1237 – 1244.en_US
dc.identifier.citedreferenceDalton HR, Fellows HJ, Stableforth W, Joseph M, Thurairajah PH, Warshow U, et al. The role of hepatitis E virus testing in drug‐induced liver injury. Aliment Pharmacol Ther 2007; 26: 1429 – 1435.en_US
dc.identifier.citedreferenceDavern TJ, Chalasani N, Fontana RJ, Hayashi PH, Protiva P, Kleiner DE, et al. Acute hepatitis E infection accounts for some cases of suspected drug‐induced liver injury. Gastroenterology 2011; 141: 1665 – 1672.en_US
dc.identifier.citedreferenceWenzel JJ, Preiss J, Schemmerer M, Huber B, Jilg W. Test performance characteristics of Anti‐HEV IgG assays strongly influence hepatitis E seroprevalence estimates. J Infect Dis 2013; 207: 497 – 500.en_US
dc.identifier.citedreferenceDrobeniuc J, Meng J, Reuter G, Greene‐Montfort T, Khudyakova N, Dimitrova Z, et al. Serologic assays specific to immunoglobulin M antibodies against hepatitis E virus: pangenotypic evaluation of performances. Clin Infect Dis 2010; 51: e24 – e27.en_US
dc.identifier.citedreferenceKhuroo MS, Kamili S, Dar MY, Moecklii R, Jameel S. Hepatitis E and long‐term antibody status. Lancet 1993; 341: 1355.en_US
dc.identifier.citedreferenceMyint KS, Endy TP, Shrestha MP, Shrestha SK, Vaughn DW, Innis BL, et al. Hepatitis E antibody kinetics in Nepalese patients. Trans R Soc Trop Med Hyg 2006; 100: 938 – 941.en_US
dc.identifier.citedreferenceDalton HR, Bendall R, Ijaz S, Banks M. Hepatitis E: an emerging infection in developed countries. Lancet Infect Dis 2008; 8: 698 – 709.en_US
dc.identifier.citedreferenceWichmann O, Schimanski S, Koch J, Kohler M, Rothe C, Plentz A, et al. Phylogenetic and case‐control study on hepatitis E virus infection in Germany. J Infect Dis 2008; 198: 1732 – 1741.en_US
dc.identifier.citedreferenceKhuroo MS, Khuroo MS. Hepatitis E virus. Curr Opin Infect Dis 2008; 21: 539 – 543.en_US
dc.identifier.citedreferenceAggarwal R. Diagnosis of hepatitis E. Nat Rev Gastroenterol Hepatol 2013; 10: 24 – 33.en_US
dc.identifier.citedreferenceTraore KA, Rouamba H, Nebie Y, Sanou M, Traore AS, Barro N, et al. Seroprevalence of fecal‐oral transmitted hepatitis A and E virus antibodies in Burkina Faso. PLoS One 2012; 7: e48125.en_US
dc.identifier.citedreferenceRossi‐Tamisier M, Moal V, Gerolami R, Colson P. Discrepancy between anti‐hepatitis E virus immunoglobulin G prevalence assessed by two assays in kidney and liver transplant recipients. J Clin Virol 2013; 56: 62 – 64.en_US
dc.identifier.citedreferenceKamar N, Bendall R, Legrand‐Abravanel F, Xia NS, Ijaz S, Izopet J, et al. Hepatitis E. Lancet 2012; 379: 2477 – 2488.en_US
dc.identifier.citedreferencePurcell RH, Emerson SU. Hepatitis E: an emerging awareness of an old disease. J Hepatol 2008; 48: 494 – 503.en_US
dc.identifier.citedreferenceBile K, Isse A, Mohamud O, Allebeck P, Nilsson L, Norder H, et al. Contrasting roles of rivers and wells as sources of drinking water on attack and fatality rates in a hepatitis E epidemic in Somalia. Am J Trop Med Hyg 1994; 51: 466 – 474.en_US
dc.identifier.citedreferenceNaik SR, Aggarwal R, Salunke PN, Mehrotra NN. A large waterborne viral hepatitis E epidemic in Kanpur, India. Bull World Health Organ 1992; 70: 597 – 604.en_US
dc.identifier.citedreferenceTeshale EH, Howard CM, Grytdal SP, Handzel TR, Barry V, Kamili S, et al. Hepatitis E epidemic, Uganda. Emerg Infect Dis 2010; 16: 126 – 129.en_US
dc.identifier.citedreferenceZhuang H, Cao XY, Liu CB, Wang GM. Epidemiology of hepatitis E in China. Gastroenterol Jpn 1991; 26 ( Suppl 3 ): 135 – 138.en_US
dc.identifier.citedreferenceSharapov MB, Favorov MO, Yashina TL, Brown MS, Onischenko GG, Margolis HS, et al. Acute viral hepatitis morbidity and mortality associated with hepatitis E virus infection: Uzbekistan surveillance data. BMC Infect Dis 2009; 9: 35.en_US
dc.identifier.citedreferenceTsega E, Hansson BG, Krawczynski K, Nordenfelt E. Acute sporadic viral hepatitis in Ethiopia: causes, risk factors, and effects on pregnancy. Clin Infect Dis 1992; 14: 961 – 965.en_US
dc.identifier.citedreferenceTsega E, Krawczynski K, Hansson BG, Nordenfelt E. Hepatitis E virus infection in pregnancy in Ethiopia. Ethiop Med J 1993; 31: 173 – 181.en_US
dc.identifier.citedreferenceSchwartz E, Jenks NP, Van DP, Galun E. Hepatitis E virus infection in travelers. Clin Infect Dis 1999; 29: 1312 – 1314.en_US
dc.identifier.citedreferenceDalton HR, Bendall R, Ijaz S, Banks M. Hepatitis E: an emerging infection in developed countries. Lancet Infect Dis 2008; 8: 698 – 709.en_US
dc.identifier.citedreferenceChapman BA, Burt MJ, Wilkinson ID, Schousboe MI. Community acquired viral hepatitis in New Zealand: a case of sporadic hepatitis E virus infection. Aust N Z J Med 1993; 23: 722 – 723.en_US
dc.identifier.citedreferenceHeath TC, Burrow JN, Currie BJ, Bowden FJ, Fisher DA, Demediuk BH, et al. Locally acquired hepatitis E in the Northern Territory of Australia. Med J Aust 1995; 162: 318 – 319.en_US
dc.identifier.citedreferenceIjaz S, Arnold E, Banks M, Bendall RP, Cramp ME, Cunningham R, et al. Non‐travel‐associated hepatitis E in England and Wales: demographic, clinical, and molecular epidemiological characteristics. J Infect Dis 2005; 192: 1166 – 1172.en_US
dc.identifier.citedreferenceMansuy JM, Peron JM, Abravanel F, Poirson H, Dubois M, Miedouge M, et al. Hepatitis E in the south west of France in individuals who have never visited an endemic area. J Med Virol 2004; 74: 419 – 424.en_US
dc.identifier.citedreferenceSainokami S, Abe K, Kumagai I, Miyasaka A, Endo R, Takikawa Y, et al. Epidemiological and clinical study of sporadic acute hepatitis E caused by indigenous strains of hepatitis E virus in Japan compared with acute hepatitis A. J Gastroenterol 2004; 39: 640 – 648.en_US
dc.identifier.citedreferenceBoutrouille A, Bakkali‐Kassimi L, Cruciere C, Pavio N. Prevalence of anti‐hepatitis E virus antibodies in French blood donors. J Clin Microbiol 2007; 45: 2009 – 2010.en_US
dc.identifier.citedreferenceButi M, Dominguez A, Plans P, Jardi R, Schaper M, Espunes J, et al. Community‐based seroepidemiological survey of hepatitis E virus infection in Catalonia, Spain. Clin Vaccine Immunol 2006; 13: 1328 – 1332.en_US
dc.identifier.citedreferenceDalton HR, Stableforth W, Thurairajah P, Hazeldine S, Remnarace R, Usama W, et al. Autochthonous hepatitis E in Southwest England: natural history, complications and seasonal variation, and hepatitis E virus IgG seroprevalence in blood donors, the elderly and patients with chronic liver disease. Eur J Gastroenterol Hepatol 2008; 20: 784 – 790.en_US
dc.identifier.citedreferenceDing X, Li TC, Hayashi S, Masaki N, Tran TH, Hirano M, et al. Present state of hepatitis E virus epidemiology in Tokyo, Japan. Hepatol Res 2003; 27: 169 – 173.en_US
dc.identifier.citedreferenceLewis HC, Wichmann O, Duizer E. Transmission routes and risk factors for autochthonous hepatitis E virus infection in Europe: a systematic review. Epidemiol Infect 2010; 138: 145 – 166.en_US
dc.identifier.citedreferenceMansuy JM, Legrand‐Abravanel F, Calot JP, Peron JM, Alric L, Agudo S, et al. High prevalence of anti‐hepatitis E virus antibodies in blood donors from South West France. J Med Virol 2008; 80: 289 – 293.en_US
dc.identifier.citedreferenceThomas DL, Yarbough PO, Vlahov D, Tsarev SA, Nelson KE, Saah AJ, et al. Seroreactivity to hepatitis E virus in areas where the disease is not endemic. J Clin Microbiol 1997; 35: 1244 – 1247.en_US
dc.identifier.citedreferenceKuniholm MH, Purcell RH, McQuillan GM, Engle RE, Wasley A, Nelson KE. Epidemiology of hepatitis E virus in the United States: results from the Third National Health and Nutrition Examination Survey, 1988‐1994. J Infect Dis 2009; 200: 48 – 56.en_US
dc.identifier.citedreferenceLi RC, Ge SX, Li YP, Zheng YJ, Nong Y, Guo QS, et al. Seroprevalence of hepatitis E virus infection, rural southern People's Republic of China. Emerg Infect Dis 2006; 12: 1682 – 1688.en_US
dc.identifier.citedreferenceMansuy JM, Legrand‐Abravanel F, Calot JP, Peron JM, Alric L, Agudo S, et al. High prevalence of anti‐hepatitis E virus antibodies in blood donors from South West France. J Med Virol 2008; 80: 289 – 293.en_US
dc.identifier.citedreferenceTanaka E, Matsumoto A, Takeda N, Li TC, Umemura T, Yoshizawa K, et al. Age‐specific antibody to hepatitis E virus has remained constant during the past 20 years in Japan. J Viral Hepat 2005; 12: 439 – 442.en_US
dc.identifier.citedreferenceBuisson Y, Grandadam M, Nicand E, Cheval P, van Cuyck‐Gandre H, Innis B, et al. Identification of a novel hepatitis E virus in Nigeria. J Gen Virol 2000; 81 ( Pt 4 ): 903 – 909.en_US
dc.identifier.citedreferencevan Cuyck‐Gandre H, Zhang HY, Tsarev SA, Clements NJ, Cohen SJ, Caudill JD, et al. Characterization of hepatitis E virus (HEV) from Algeria and Chad by partial genome sequence. J Med Virol 1997; 53: 340 – 347.en_US
dc.identifier.citedreferenceTam AW, Smith MM, Guerra ME, Huang CC, Bradley DW, Fry KE, et al. Hepatitis E virus (HEV): molecular cloning and sequencing of the full‐length viral genome. Virology 1991; 185: 120 – 131.en_US
dc.identifier.citedreferenceMeng XJ. From barnyard to food table: the omnipresence of hepatitis E virus and risk for zoonotic infection and food safety. Virus Res 2011; 161: 23 – 30.en_US
dc.identifier.citedreferenceShukla P, Nguyen HT, Torian U, Engle RE, Faulk K, Dalton HR, et al. Cross‐species infections of cultured cells by hepatitis E virus and discovery of an infectious virus‐host recombinant. Proc Natl Acad Sci U S A 2011; 108: 2438 – 2443.en_US
dc.identifier.citedreferenceTakahashi H, Tanaka T, Jirintai S, Nagashima S, Takahashi M, Nishizawa T, et al. A549 and PLC/PRF/5 cells can support the efficient propagation of swine and wild boar hepatitis E virus (HEV) strains: demonstration of HEV infectivity of porcine liver sold as food. Arch Virol 2012; 157: 235 – 246.en_US
dc.identifier.citedreferenceZhao C, Ma Z, Harrison TJ, Feng R, Zhang C, Qiao Z, et al. A novel genotype of hepatitis E virus prevalent among farmed rabbits in China. J Med Virol 2009; 81: 1371 – 1379.en_US
dc.identifier.citedreferenceTang X, Yang C, Gu Y, Song C, Zhang X, Wang Y, et al. Structural basis for the neutralization and genotype specificity of hepatitis E virus. Proc Natl Acad Sci U S A 2011; 108: 10266 – 10271.en_US
dc.identifier.citedreferenceBendall R, Ellis V, Ijaz S, Ali R, Dalton H. A comparison of two commercially available anti‐HEV IgG kits and a re‐evaluation of anti‐HEV IgG seroprevalence data in developed countries. J Med Virol 2010; 82: 799 – 805.en_US
dc.identifier.citedreferenceGhabrah TM, Tsarev S, Yarbough PO, Emerson SU, Strickland GT, Purcell RH. Comparison of tests for antibody to hepatitis E virus. J Med Virol 1998; 55: 134 – 137.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
hep27219.pdf
Size:
423.6KB
Format:
PDF
View/Open
Name:
hep27219-sup-0001-suppinfo.pdf
Size:
942.6KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.